# Biologics in Folliculitis Decalvans : an Adaptative Trial Research

> **NCT07268534** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 120 (estimated)

## Conditions studied

- Folliculitis Decalvans (FD)

## Interventions

- **DRUG:** Adalimumab
- **DRUG:** Ustekinumab
- **DRUG:** Baricitinib

## Key facts

- **NCT ID:** NCT07268534
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2029-11-01
- **Final completion:** 2030-04-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07268534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07268534, "Biologics in Folliculitis Decalvans : an Adaptative Trial Research". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07268534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*